-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Announces Third Biosimilar FDA Approval of FYLNETRA
-
-
-
-
-
-
-
Mereo BioPharma (MREO) Announces the Presentation of Updated Data From a Phase 1b/2 Study of Etigilimab as a Poster at the 2022 American Society of Clinical Oncology Annual Meeting
-
-
-
-
-
-
-
PDS Biotechnology (PDSB) Announces Presentation of Efficacy and Safety Data from VERSATILE-002 Phase 2 Clinical Trial in Recurrent or Metastatic Head and Neck Cancer at ASCO
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Reports Phase 2 PILOT Study Data of CAR T cell Therapy Breyanzi Shows Substantial Durable Responses
-
-
-
-
-
-
-
Y-mAbs Therapeutics (YMAB) Announces Naxitamab Chemoimmunotherapy Investigational Trial for High-Risk Neuroblastoma Meets Primary Endpoint
-
-
-
-
-
-
-
Co-Diagnostics (CODX) Announces Completion of Principal Design of Test for Monkeypox Virus
-
-
-
-
-
-
-
OpGen (OPGN) Reports Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel
-
58,087 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.